Lawsuit filed for Investors in shares of STAAR Surgical Company (NASDAQ: STAA)

An investor, who purchased shares of STAAR Surgical Company (NASDAQ: STAA), filed a lawsuit over alleged violations of Federal Securities Laws by STAAR Surgical Company.

Investors who purchased shares of STAAR Surgical Company (NASDAQ: STAA) have certain options and for certain investors are short and strict deadlines running. Deadline: October 19, 2020. NASDAQ: STAA investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Lake Forest, CA based STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye.

On August 11, 2020, a report was published calling into STAAR’s purported success in China. The report accused STAAR Surgical Company of overstating its sales in China by at least one-third (or $21.6 million), “meaning all of the company’s $14 mln in 2019 profit is fake.” The report is allegedly based on “over 75 interviews”, as well as visits to STAAR Surgical Company locations in China and Switzerland. In particular, the report concluded that AIER’s financial statements indicate that it bought only about half as many lenses as STAAR Surgical Company reported. Shares of STAAR Surgical Company (NASDAQ: STAA) declined from $62.25 per share on July 2, 2020 to $46.01 per share on August 14, 2020.

The plaintiff claims that between February 26, 2020 and August 10 2020, the defendants misrepresented and/or failed to disclose to investors that the Company was overstating and/or mischaracterizing: (1) its sales and growth in China; (2) its marketing spend; (3) its research and development expenses; and that as a result of the foregoing, (4) defendants’ public statements were materially false and misleading at all relevant times.

Those who purchased shares of STAAR Surgical Company (NASDAQ: STAA) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.